TrialThe Journal of dermatology2017

Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.

Masatoshi Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.